INS and Hypoglycemia: We built on existing literature identifying sulfonylurea and insulin use as important hypoglycemia risk factors23,24,25,32 by examining these medications in parallel with other relevant risk factors, differentiating between basal insulin and basal plus bolus insulin regimens and exploring the implications of concurrent sulfonylurea and insulin use.